Description

Product details

Loteprednol etabonate ophthalmic suspension is a prescription corticosteroid eye drop used to treat steroid-responsive inflammatory conditions of the eye, including post-surgical inflammation, allergic conjunctivitis, and certain forms of anterior uveitis. What sets loteprednol apart from older ophthalmic steroids is its “ester-based” chemical structure, which is designed to break down into inactive components after acting on eye tissue — giving it a comparatively lower risk of raising intraocular pressure (IOP) than traditional steroids like prednisolone or dexamethasone, while still delivering effective anti-inflammatory action. The typical dose is one to two drops in the affected eye, four times daily, or as directed, usually for a short, defined course rather than indefinite use. Common side effects include burning, stinging, and blurred vision, while prolonged or unsupervised use can still carry steroid-related risks such as elevated eye pressure. It is a Schedule H prescription-only medicine in India. What Is Loteprednol Etabonate Ophthalmic Suspension? Loteprednol etabonate ophthalmic suspension is a topical corticosteroid formulated specifically for use in the eye. It belongs to a category sometimes referred to as “site-specific” or “soft” steroids — a design approach where the drug is engineered to be highly active at the site of application (the eye) but rapidly metabolized into inactive by-products once it has acted, reducing the potential for the cumulative steroid-related side effects seen with older ophthalmic corticosteroids. This suspension is commonly prescribed for: Managing inflammation following eye surgery, such as cataract surgery Treating allergic conjunctivitis, including seasonal allergic conjunctivitis Certain anterior segment inflammatory conditions, such as uveitis, under specialist supervision Giant papillary conjunctivitis and other steroid-responsive ocular surface conditions Because of its comparatively favorable IOP profile, loteprednol is often considered by ophthalmologists for patients who need effective anti-inflammatory therapy but may be at higher risk from more potent steroids — though it is important to note that no ophthalmic steroid is entirely free of IOP-related risk, and monitoring remains necessary. How Does Loteprednol Etabonate Work? (Mechanism of Action) Corticosteroid receptor binding – Loteprednol etabonate binds to glucocorticoid receptors within ocular tissue, initiating anti-inflammatory gene expression changes. Suppression of inflammatory mediators – This binding reduces the production of key inflammatory substances, including prostaglandins and cytokines, that drive redness, swelling, and discomfort. Reduced vascular permeability – By calming the inflammatory cascade, the drug helps reduce leakage of fluid and inflammatory cells into ocular tissue, easing swelling. Ester-based metabolism – Unlike ketone-based steroids, loteprednol's ester structure allows ocular esterases to break it down into inactive metabolites after it exerts its effect, which is thought to underlie its comparatively lower propensity to raise intraocular pressure. Localized anti-inflammatory effect – The net result is effective control of ocular surface and anterior segment inflammation with a more favorable safety profile than some older steroid formulations, when used for the intended short duration. Clinical Indications IndicationDetailsPost-operative ocular inflammationCommon after cataract and other intraocular surgeriesAllergic conjunctivitisIncluding seasonal allergic conjunctivitisGiant papillary conjunctivitisOften associated with contact lens wearAnterior uveitisUnder specialist supervisionOther steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segmentAs directed by an ophthalmologist Not indicated for: viral (e.g., herpes simplex), fungal, or mycobacterial eye infections, where corticosteroid use can worsen the underlying condition. Dosage & Administration ParameterRecommendationStandard dose1–2 drops in the affected eye(s), typically 4 times dailyPost-surgical regimenOften started at higher frequency and tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationShort, defined course as prescribed; not intended for indefinite useTaperingGradual reduction recommended rather than abrupt discontinuation after extended useContact lensesRemove before instillation; reinsert only per your doctor's adviceMissed doseApply as soon as remembered; do not double the next dose Important: Even with its comparatively favorable safety profile, loteprednol should be used strictly for the duration prescribed. Extended, unsupervised use is not recommended. Key Benefits Effective anti-inflammatory action for a range of steroid-responsive ocular conditions Ester-based design associated with a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids Useful for patients needing steroid therapy who may be more sensitive to IOP elevation, under appropriate monitoring Suitable for both post-surgical inflammation control and allergic conjunctivitis management Available in a suspension formulation designed for good ocular surface contact Often used as part of a short, defined treatment course, reducing exposure duration compared to continuous long-term steroid regimens Precautions Use strictly under ophthalmologist supervision — this is not an over-the-counter product Not suitable for viral, fungal, or mycobacterial eye infections Even with its favorable profile, prolonged use can still raise intraocular pressure in susceptible individuals — periodic IOP monitoring is recommended Extended use may increase the risk of cataract formation, as with other ophthalmic steroids May mask signs of infection or delay wound healing if used inappropriately Inform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting Shake the suspension well before each use for accurate dosing Avoid touching the dropper tip to the eye or any surface Side Effects Common (Usually Mild and Temporary) Burning or stinging sensation on instillation Blurred vision immediately after application Eye discomfort or a foreign-body sensation Mild eye redness Less Common / Serious (Consult Your Doctor Promptly) Elevated intraocular pressure (comparatively less frequent than with older steroids, but still possible) Delayed wound healing Signs of secondary or masked ocular infection Cataract progression with prolonged use Allergic reaction (eyelid swelling, itching, rash) Discontinue and consult your ophthalmologist promptly if any serious symptom develops. Comparison: Loteprednol vs. Other Ophthalmic Corticosteroids TreatmentClassIOP Risk ProfileBest Suited ForLoteprednol etabonate suspensionEster-based (“soft”) corticosteroidComparatively lowerPatients needing effective anti-inflammatory action with reduced IOP concernPrednisolone acetateKetone-based corticosteroidHigher with prolonged useRobust anti-inflammatory action; requires closer IOP monitoringDexamethasoneKetone-based corticosteroidHigher, potent effectSevere inflammatory conditions; typically shorter coursesFluorometholoneKetone-based corticosteroidModerateMild to moderate inflammation with somewhat reduced IOP risk Key Statistics (Placeholder — Pending Clinical Reviewer Verification) MetricValueReported incidence of clinically significant IOP elevation with short-course loteprednol use[Placeholder – insert verified clinical trial statistic]Comparative IOP-elevation rate vs. prednisolone acetate in controlled studies[Placeholder – insert verified reference]Typical duration of post-operative loteprednol therapy[Placeholder – insert reference range] All statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication. Expert Insight [Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.] Price of Loteprednol Etabonate Ophthalmic Suspension The price of loteprednol etabonate ophthalmic suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy. Prescription only – consult your doctor. Conclusion Loteprednol etabonate ophthalmic suspension offers a valuable option for managing steroid-responsive ocular inflammation — from post-surgical recovery to allergic conjunctivitis — with a design intended to reduce the intraocular pressure risks historically associated with ophthalmic corticosteroids. While its ester-based structure gives it a comparatively favorable safety profile, it remains a steroid, and prolonged or unsupervised use can still carry risks such as elevated eye pressure, cataract progression, and delayed healing. For this reason, loteprednol should always be used for the specific duration prescribed, with appropriate tapering and regular ophthalmic follow-up, rather than as a long-term, self-managed therapy. Frequently Asked Questions 1. What is loteprednol etabonate ophthalmic suspension used for? It is used to treat steroid-responsive eye inflammation, including inflammation after eye surgery, allergic conjunctivitis, and certain anterior segment inflammatory conditions such as uveitis, under an ophthalmologist's guidance. 2. Is loteprednol a steroid? Yes, loteprednol etabonate is a corticosteroid. It is specifically designed with an ester-based structure intended to reduce the risk of raising intraocular pressure compared to some older ophthalmic steroids, though it still requires medical supervision. 3. How long can I use loteprednol eye drops? Loteprednol is typically prescribed for a short, defined course as determined by your ophthalmologist, often with a tapering schedule. It is not intended for indefinite, unsupervised long-term use. 4. Does loteprednol raise eye pressure? Loteprednol has a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids due to its ester-based design, but it can still cause elevated eye pressure in susceptible individuals, especially with prolonged use, so periodic monitoring is recommended. 5. Can loteprednol cause cataracts? Prolonged use of any ophthalmic corticosteroid, including loteprednol, can increase the risk of cataract formation, particularly posterior subcapsular cataracts, which is why short, supervised courses are recommended. 6. How is loteprednol different from prednisolone acetate? Loteprednol has an ester-based chemical structure designed to break down into inactive components after acting on the eye, which is associated with a lower risk of raising intraocular pressure compared to prednisolone acetate, a ketone-based steroid with a higher IOP-elevation potential. 7. Can loteprednol be used for allergic conjunctivitis? Yes, loteprednol etabonate ophthalmic suspension is commonly used to manage allergic conjunctivitis, including seasonal allergic conjunctivitis, especially when symptoms are significant or not controlled by other treatments. 8. Is loteprednol safe after cataract surgery? Yes, loteprednol is frequently prescribed to manage post-operative inflammation following cataract surgery, typically as part of a tapering regimen directed by the operating ophthalmologist. 9. Can loteprednol be used for viral eye infections? No, loteprednol and other corticosteroids are not appropriate for viral eye infections such as herpes simplex keratitis, as steroids can worsen these conditions if used inappropriately. 10. What are the common side effects of loteprednol eye drops? Common side effects include burning or stinging upon application, temporary blurred vision, mild eye redness, and eye discomfort. These are usually mild and resolve quickly. 11. Does loteprednol need to be shaken before use? Yes, since it is a suspension, the bottle should be shaken well before each use to ensure the medication is evenly distributed. 12. Can loteprednol be stopped suddenly? Stopping abruptly, especially after extended use, is generally not recommended. A gradual tapering schedule, as advised by your ophthalmologist, helps prevent rebound inflammation. 13. Is loteprednol safe for long-term daily use? No, loteprednol is generally intended for short, supervised courses rather than continuous long-term daily use, due to steroid-related risks with prolonged exposure. 14. Can contact lenses be worn while using loteprednol? It's generally recommended to remove contact lenses before applying loteprednol and reinsert them only after the interval advised by your doctor. 15. Who should avoid using loteprednol eye drops? Patients with active untreated viral, fungal, or mycobacterial eye infections, or known hypersensitivity to the medication, should avoid loteprednol unless specifically directed otherwise by their ophthalmologist. 16. Can loteprednol be used in children? Use in children should only occur under the direct guidance and prescription of a pediatric ophthalmologist, based on individual clinical assessment. 17. Does loteprednol cause blurred vision? Temporary blurred vision can occur immediately after instillation in some patients and usually resolves quickly. Persistent blurred vision should be reported to your doctor.

Other Specifications